Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -26.03% is 237% below its 5-year average of 18.95%, near the low end of its 5-year range (-39.74%–34.72%).
As of the fiscal period ended Tuesday, March 31, 2026. 250.80% below its 12-month average of 17.26%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
-26.03%
NET PROFIT MARGIN AVG TTM
17.26%
NET PROFIT MARGIN AVG 3Y
26.85%
NET PROFIT MARGIN AVG 5Y
26.23%
NET PROFIT MARGIN AVG 10Y
21.55%
NET PROFIT MARGIN AVG 15Y
17.37%
NET PROFIT MARGIN AVG 20Y
17.63%
CURRENT VS TTM AVG
-250.80%
CURRENT VS 3Y AVG
-196.96%
CURRENT VS 5Y AVG
-199.25%
CURRENT VS 10Y AVG
-220.83%
CURRENT VS 15Y AVG
-249.90%
CURRENT VS 20Y AVG
-247.67%
SECTOR MEDIAN · HEALTHCARE
10.44%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-349.37%
vs the sector median at left
Merck & Co., Inc.
Market Cap
$323.72B
Net Profit Margin
-26.03%
TTM Avg
17.26%
3Y Avg
26.85%
5Y Avg
26.23%
Market Cap
$382.09B
Net Profit Margin
3.14%
TTM Avg
3.15%
3Y Avg
4.63%
5Y Avg
5.09%
Market Cap
$262.31B
Net Profit Margin
17.19%
TTM Avg
15.23%
3Y Avg
12.72%
5Y Avg
10.53%
Market Cap
$216.72B
Net Profit Margin
37.14%
TTM Avg
33.96%
3Y Avg
33.83%
5Y Avg
33.74%
Market Cap
$211.18B
Net Profit Margin
15.06%
TTM Avg
14.95%
3Y Avg
14.84%
5Y Avg
16.47%
Market Cap
$179.58B
Net Profit Margin
11.65%
TTM Avg
23.34%
3Y Avg
19.20%
5Y Avg
17.71%
Market Cap
$160.55B
Net Profit Margin
30.99%
TTM Avg
15.29%
3Y Avg
17.07%
5Y Avg
15.27%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Merck & Co., Inc. (MRK) | $323.72B | -26.03% | 17.26% | 26.85% | 26.23% |
| UnitedHealth Group Incorporated (UNH)vs › | $382.09B | 3.14% | 3.15% | 4.63% | 5.09% |
| AstraZeneca PLC (AZN)vs › | $262.31B | 17.19% | 15.23% | 12.72% | 10.53% |
| Novo Nordisk A/S (NVO)vs › | $216.72B | 37.14% | 33.96% | 33.83% | 33.74% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $211.18B | 15.06% | 14.95% | 14.84% | 16.47% |
| Amgen Inc. (AMGN)vs › | $202.95B | 20.95% | 16.61% | 20.49% | 22.20% |
| AbbVie Inc. (ABBV)vs › | $458.11B | 5.79% | 7.25% | 10.96% | 12.41% |
| Abbott Laboratories (ABT)vs › | $179.58B | 11.65% | 23.34% | 19.20% | 17.71% |
| Gilead Sciences, Inc. (GILD)vs › | $160.55B | 30.99% | 15.29% | 17.07% | 15.27% |
| Pfizer Inc. (PFE)vs › | $139.86B | 11.83% | 12.51% | 14.97% | 18.18% |
Operating Margin
36.2%
Net Profit Margin
-26.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | -26.03% |
| 2025-12-31 | 18.15% |
| 2025-09-30 | 33.67% |
| 2025-06-30 | 28.02% |
| 2025-03-31 | 32.52% |
| 2024-12-31 | 23.96% |
| 2024-09-30 | 18.95% |
| 2024-06-30 | 33.86% |
| 2024-03-31 | 30.19% |
| 2023-12-31 | -8.38% |
| 2023-09-30 | 29.73% |
| 2023-06-30 | -39.74% |
| 2023-03-31 | 19.47% |
| 2022-12-31 | 21.81% |
| 2022-09-30 | 21.71% |
| 2022-06-30 | 27.03% |
| 2022-03-31 | 27.11% |
| 2021-12-31 | 27.79% |
| 2021-09-30 | 34.72% |
| 2021-06-30 | 13.55% |
| 2021-03-31 | 29.91% |
| 2020-12-31 | -16.73% |
| 2020-09-30 | 26.91% |
| 2020-06-30 | 32.10% |
| 2020-03-31 | 26.70% |
| 2019-12-31 | 19.85% |
| 2019-09-30 | 15.33% |
| 2019-06-30 | 22.70% |
| 2019-03-31 | 26.95% |
| 2018-12-31 | 16.61% |
| 2018-09-30 | 18.07% |
| 2018-06-30 | 16.31% |
| 2018-03-31 | 7.33% |
| 2017-12-31 | -10.03% |
| 2017-09-30 | -0.54% |
| 2017-06-30 | 19.60% |
| 2017-03-31 | 16.44% |
| 2016-12-31 | -5.88% |
| 2016-09-30 | 20.73% |
| 2016-06-30 | 12.24% |
| 2016-03-31 | 12.08% |
| 2015-12-31 | 9.56% |
| 2015-09-30 | 18.13% |
| 2015-06-30 | 7.02% |
| 2015-03-31 | 10.11% |
| 2014-12-31 | 69.80% |
| 2014-09-30 | 8.48% |
| 2014-06-30 | 18.33% |
| 2014-03-31 | 16.61% |
| 2013-12-31 | 6.90% |
| 2013-09-30 | 10.19% |
| 2013-06-30 | 8.23% |
| 2013-03-31 | 14.93% |
| 2012-12-31 | 7.73% |
| 2012-09-30 | 15.05% |
| 2012-06-30 | 14.56% |
| 2012-03-31 | 14.82% |
| 2011-12-31 | 12.30% |
| 2011-09-30 | 14.07% |
| 2011-06-30 | 16.66% |
| 2011-03-31 | 9.01% |
| 2010-12-31 | -4.40% |
| 2010-09-30 | 3.07% |
| 2010-06-30 | 6.63% |
| 2010-03-31 | 2.62% |
| 2009-12-31 | 64.36% |
| 2009-09-30 | 56.60% |
| 2009-06-30 | 26.38% |
| 2009-03-31 | 26.46% |
| 2008-12-31 | 27.27% |
| 2008-09-30 | 18.38% |
| 2008-06-30 | 29.22% |
| 2008-03-31 | 56.73% |
| 2007-12-31 | -26.12% |
| 2007-09-30 | 25.11% |
| 2007-06-30 | 27.43% |
| 2007-03-31 | 29.54% |
| 2006-12-31 | 7.84% |
| 2006-09-30 | 17.39% |
| 2006-06-30 | 25.98% |
| 2006-03-31 | 28.10% |
| 2005-12-31 | 19.42% |
| 2005-09-30 | 26.23% |
| 2005-06-30 | 13.18% |
| 2005-03-31 | 25.55% |
| 2004-12-31 | 19.16% |
| 2004-09-30 | 23.94% |
| 2004-06-30 | 29.36% |
| 2004-03-31 | 28.75% |
| 2003-12-31 | 24.79% |
| 2003-09-30 | 32.25% |
| 2003-06-30 | 33.79% |
| 2003-03-31 | 30.70% |
| 2002-12-31 | 13.58% |
| 2002-09-30 | 34.72% |
| 2002-06-30 | 13.67% |
